Effects of Retinoids on the Mucosal Immune System
Effects of Retinoids on the Mucosal Immune System
批准号:
8376296
负责人:
Michael Karin
金额:
$25.83万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Animal ModelAnti-Inflammatory AgentsAnti-inflammatoryAntigensCD4 Positive T LymphocytesCellsDevelopmentDietDrug Delivery SystemsEffector CellEnvironmentEpigenetic ProcessEquilibriumFoodGenerationsGenesGenetic TranscriptionGoalsImmuneImmune ToleranceImmune responseImmune systemImmunityImmunosuppressionIn VitroInflammatoryInflammatory Bowel DiseasesInstructionInterleukin-17InterventionIntestinesInvadedKnowledgeLeadMediatingMedicalModificationNuclear ReceptorsPathway interactionsPlayRegulationRegulatory T-LymphocyteRetinoidsRoleSignal TransductionStimulusT cell differentiationT-LymphocyteTestingTissue-Specific Gene ExpressionTranscriptional RegulationTretinoinVitamin Acytokineenteric pathogenflexibilityimprovedin vivoinsightmicrobialmicroorganism antigennovelpathogenpreventprogramspromoter
中文摘要
点击翻译按钮获取中文摘要
英文摘要
instmctions):
The simultaneous constraint of highly efficient protective immunity together with the prerequisite for
tolerance towards innocuous antigens Imposes a significant challenge for the intesfinal mucosal immune
system. Several mechanisms operating in different types of DCs and/or T cells have been identified that
control immune tolerance and protective immunity. TGF-|3 in particular is a crucial regulator capable of
inducing FoxpS+Tregs, but paradoxically, in the presence of pro-inflammatory cytokines, promoting the
conversion to Thi7 effector cells. This contrasting deviation puts TGF-(3 as a principal controller of pro- and
anti-inflammatory immune responses. Recently we demonstrated that retinoic acid and other retinoids
function as key regulators of the TGF-P-dependent immune deviation, capable of inhibiting the induction of
proinflammatory Thi7 cells but promoting the TGF-P-dependent differentiation of anti-inflammatory
FoxpS+lTregs. We further showed that in the absence of innate danger signals, retinoids can be absorbed
and released by the DCs to the T cells they prime. The released retinoids then directly target differential
gene expression within the T cell to promote anti-inflammatory and tolerant immunity. In the presence of
danger signals sensed by the DCs, retinoids no longer suppress pro-inflammatory differentiation of primed
T cells, suggesting that under innate stimulation conditions, retinoid-mediated suppressive effects on T
cells are abolished and/or that retinoid signaling in the presence of innate stimuli can turn towards the DCs
and promote their antigen presenting function and protective immune responses. The study proposed
here, aims at elucidating retinoid-mediated mechanisms that operate in T cells or DCs and that control the
balance between tolerance and protective immunity. The indicated collaborative approaches with Units 1,2
and 3 of this PPG, will allow us to extend this study and evaluate the potential cross talk between the
retinoid pathways and other cellular mechanisms involved in immune regulation, as well as the role of
retinoid-mediated control in directing immune responses towards specific pathogens, using various
infecfious animal models.
RELEVANCE (See instructions):
The knowledge gained from this study will expand our understanding of regulation of pro- and anti¿
inflammatory immune responses, in particular involving mechanisms employed by the mucosal immune
system to control local and systemic immunity. The study has also great potential for the identiflcation of
new drug targets that may improve exisfing therapies or may lead to the development of novel medical
intervention opportunities to prevent and/or treat intestinal inflammatory diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NF-kappaB and Mitochondrial Signals as Positive and Negative Regulators of Inflammation
-
批准号:10516935
-
项目类别:
-
资助金额:$60.06万
-
财政年份:2023
-
负责人:Michael Karin
-
依托单位:
A new mouse model for studying the pathogenesis and immunobiology of intrahepatic cholangiocarcinoma and improving its immunotherapy
-
批准号:10711615
-
项目类别:
-
资助金额:$56.39万
-
财政年份:2023
-
负责人:Michael Karin
-
依托单位:
Regulation of PDAC metabolism and immunity by collagen and its cleavage products
-
批准号:10708168
-
项目类别:
-
资助金额:$95.5万
-
财政年份:2022
-
负责人:Michael Karin
-
依托单位:
Regulation of PDAC metabolism and immunity by collagen and its cleavage products
-
批准号:10517874
-
项目类别:
-
资助金额:$97.11万
-
财政年份:2022
-
负责人:Michael Karin
-
依托单位:
The NRF2-FBP1 crossregulatory loop and the control of healthy and diseased liver metabolism
-
批准号:10503841
-
项目类别:
-
资助金额:$70.53万
-
财政年份:2022
-
负责人:Michael Karin
-
依托单位:
The NRF2-FBP1 crossregulatory loop and the control of healthy and diseased liver metabolism
-
批准号:10670920
-
项目类别:
-
资助金额:$68.44万
-
财政年份:2022
-
负责人:Michael Karin
-
依托单位:
The effect of cancer cell produced collagen 1 homotrimers on DDR1 signaling activation by microenvironmental collagen 1 fragments.
-
批准号:10831212
-
项目类别:
-
资助金额:$17.45万
-
财政年份:2022
-
负责人:Michael Karin
-
依托单位:
NF-kappaB and Mitochondrial Signals as Positive and Negative Regulators of Inflammation
-
批准号:10182897
-
项目类别:
-
资助金额:$37.17万
-
财政年份:2020
-
负责人:Michael Karin
-
依托单位:
NF-kappaB and Mitochondrial Signals as Positive and Negative Regulators of Inflammation
-
批准号:10266224
-
项目类别:
-
资助金额:$3.38万
-
财政年份:2020
-
负责人:Michael Karin
-
依托单位:
Control of Lipogenesis and Hepatic Steatosis by Caspase-2
-
批准号:10322660
-
项目类别:
-
资助金额:$41.77万
-
财政年份:2019
-
负责人:Michael Karin
-
依托单位:
Control of Lipogenesis and Hepatic Steatosis by Caspase-2
-
批准号:10735256
-
项目类别:
-
资助金额:$54.63万
-
财政年份:2019
-
负责人:Michael Karin
-
依托单位:
Control of Lipogenesis and Hepatic Steatosis by Caspase-2
-
批准号:10083211
-
项目类别:
-
资助金额:$41.71万
-
财政年份:2019
-
负责人:Michael Karin
-
依托单位:
Control of Lipogenesis and Hepatic Steatosis by Caspase-2
-
批准号:9886239
-
项目类别:
-
资助金额:$41.64万
-
财政年份:2019
-
负责人:Michael Karin
-
依托单位:
Highly penetrant and immunogenic mouse models of non-viral HCC that are suitable for evaluation of immune checkpoint inhibitors
-
批准号:10304916
-
项目类别:
-
资助金额:$54.24万
-
财政年份:2018
-
负责人:Michael Karin
-
依托单位:
Highly penetrant and immunogenic mouse models of non-viral HCC that are suitable for evaluation of immune checkpoint inhibitors
-
批准号:10056211
-
项目类别:
-
资助金额:$55.25万
-
财政年份:2018
-
负责人:Michael Karin
-
依托单位:
Highly penetrant and immunogenic mouse models of non-viral HCC that are suitable for evaluation of immune checkpoint inhibitors
-
批准号:10533278
-
项目类别:
-
资助金额:$54.24万
-
财政年份:2018
-
负责人:Michael Karin
-
依托单位:
The Role of IL-17 in Alcoholic Liver Disease and Cancer
-
批准号:8913875
-
项目类别:
-
资助金额:$34.27万
-
财政年份:2014
-
负责人:Michael Karin
-
依托单位:
The Role of IL-17 in Alcoholic Liver Disease and Cancer
-
批准号:9088220
-
项目类别:
-
资助金额:$35.33万
-
财政年份:2014
-
负责人:Michael Karin
-
依托单位:
The Role of IL-17 in Alcoholic Liver Disease and Cancer
-
批准号:8761112
-
项目类别:
-
资助金额:$36.68万
-
财政年份:2014
-
负责人:Michael Karin
-
依托单位:
IKKalpha, autophagy, obesity and injury enhanced pancreatic cancer
-
批准号:8511588
-
项目类别:
-
资助金额:$35.99万
-
财政年份:2012
-
负责人:Michael Karin
-
依托单位:
海外基金